Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease. [electronic resource] by
- Hirsh, Andrew J
- Zhang, Jim
- Zamurs, Andra
- Fleegle, Jacquelyn
- Thelin, William R
- Caldwell, Ray A
- Sabater, Juan R
- Abraham, William M
- Donowitz, Mark
- Cha, Boyoung
- Johnson, Kevin B
- St George, Judith A
- Johnson, M Ross
- Boucher, Richard C
Producer: 20080422
In:
The Journal of pharmacology and experimental therapeutics vol. 325
Availability: No items available.
|
|
|
18.
|
|
|
|
19.
|
|
|
|
20.
|
|